Renal cell carcinoma and interferon at the millennium.
Pastore
R D
RD
Division of Hematology and Medical Oncology, Department of Medicine, Joan and Sanford I. Weill Medical College of Cornell University, New York, New York, USA.
Pfeffer
L M
LM
Nanus
D M
DM
D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy*; D003131:Combined Modality Therapy; D006801:Humans; D016898:Interferon-alpha / Q000494:pharmacology / Q000627:therapeutic use*; D007371:Interferon-gamma / Q000494:pharmacology / Q000627:therapeutic use; D007376:Interleukin-2 / Q000627:therapeutic use; D007680:Kidney Neoplasms / Q000188:drug therapy*; D011505:Protein-Tyrosine Kinases / Q000378:metabolism; D015398:Signal Transduction
D000970:Antineoplastic Agents; D016898:Interferon-alpha; D007376:Interleukin-2; D007371:Interferon-gamma; D011505:Protein-Tyrosine Kinases